San Francisco startup Framework Therapeutics can be working on an oral, as soon as-each day GLP-one drug called GSBR-1290—the drug surpassed Wall Road’s expectations in June each time a mid-phase review showed normal weight loss of all over 6% and it strategies to begin One more mid-phase trial towards the top of the 12 months—that founder an